Content area
Abstract
[...] some doubt is appropriate: "treatment X seems superior to treatment Y" or "patients receiving treatment X had significantly fewer primary events". [...] any reliable claim of safety needs longer follow-up than the trial's 9 months. p^sub NI^<0.05 provides evidence of non-inferiority and the new treatment "seems non-inferior" or "seems to have similar efficacy to the standard treatment".





